Poland - Vaccines

Description

The subject of the contract is: Delivery of combined vaccine against diphtheria, tetanus, pertussis (cell-free, complex), poliomyelitis (inactivated) and heamophilus influenzae type B - inj. 0.5 ml.; Parts: 1÷5 .The Purchaser reserves the right to reduce the purchase of medicinal products, but not by more than 20% of the total subject matter of the contract in the event of exceeding the amount allocated for the execution of the contract or the emergence of objective and justified needs, in particular changes in demand among patients. Pursuant to Art. 257 of the PPL Act. The Contracting Authority shall have the right to cancel the public procurement procedure if the funds that he intended to use for financing the whole or part of the contract were not granted to him.
Supply of combined vaccine against: diphtheria, tetanus, pertussis (cell-free, complex), poliomyelitis (inactivated) and Haemophilus influenzae type B - inj. 0.5 ml, to complete the schemes started with Pentaxim vaccine in the number of 3 000 doses 1. SUBJECT MATERIALS:1.1 Pursuant to art. 105 and art. 106 of the Public Procurement Act. In order to confirm compliance of the supplies offered with the requirements, features or criteria specified in the description of the subject matter of the contract or criteria for evaluation of tenders or requirements connected with performance of the contract, the Contracting Authority requires contractors to present:- a valid, up-to-date marketing authorization for the medicinal product in the territory of the Republic of Poland issued by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products,or- a valid, up-to-date marketing authorization for the medicinal product issued by the Council of the European Union or the European Commission,1.Pursuant to Article 107 (1) of the PPL Act, the Economic Operator shall submit the above mentioned means of evidence together with the tender1.3 The Economic Operator shall inform the Contracting Authority if he transfers to another entity the rights and obligations of the responsible entity arising from the Marketing Authorisation for the medicinal product.1.4 The marketing authorisation for the medicinal product must be valid and up-to-date as of the date on which tenders are submitted.1.5 The composition of the preparation and the packaging must comply with the content of the documents referred to in item 1.1.1.6 If the validity of the document expires, the Contractor shall submit to the Contracting Authority, together with the documents referred to in item 1.1, an additional document declaring that an application for renewal of the marketing authorisation for the medicinal product has been submitted in due time or, if granted, a valid marketing authorisation for the medicinal product.1.7 The aforementioned documents shall be valid for the entire period of performance of the contract.1.8 The documents referred to above shall be submitted in the manner prescribed in regulations issued pursuant to Article 70 of the PPL Act.1.9 The Contracting Authority, pursuant to Article 107, paragraph 2 of the PPL Act, shall provide for the possibility of supplementing the aforementioned means of evidence once.1.10 Documents prepared in a foreign language shall be submitted with a translation into Polish. Supply of a combined vaccine against: diphtheria, tetanus, pertussis (cell-free, complex), poliomyelitis (inactivated) and Haemophilus influenzae type B - 0.5 ml inj. 1.1 Pursuant to Article 105 and Article 106 of the Act on Public Procurement. to confirm compliance of the supplies offered with the requirements, features or criteria specified in the description of the subject matter of the contract or with the criteria for evaluation of tenders or requirements connected with performance of the contract, the Contracting Authority shall require contractors to present:- a valid, up-to-date marketing authorisation for the medicinal product in the territory of the Republic of Poland issued by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products,or- a valid, up-to-date marketing authorisation for the medicinal product issued by the Council of the European Union or the European Commission,1.Pursuant to Article 107 (1) of the PPL Act, the Economic Operator shall submit the above mentioned means of evidence together with the tender1.3 The Economic Operator shall inform the Contracting Authority if he transfers to another entity the rights and obligations of the responsible entity arising from the Marketing Authorisation for the medicinal product.1.4 The marketing authorisation for the medicinal product must be valid and up-to-date as of the date on which tenders are submitted.1.5 The composition of the preparation and the packaging must comply with the content of the documents referred to in item 1.1.1.6 If the validity of the document expires, the Contractor shall submit to the Contracting Authority, together with the documents referred to in item 1.1, an additional document declaring that an application for renewal of the marketing authorisation for the medicinal product has been submitted in due time or, if granted, a valid marketing authorisation for the medicinal product.1.7 The aforementioned documents shall be valid for the entire period of performance of the contract.1.8 The documents referred to above shall be submitted in the manner prescribed in regulations issued pursuant to Article 70 of the PPL Act.1.9 The Contracting Authority pursuant to Article 107(2) of the PPL Act shall provide for the possibility of supplementing the aforementioned means of evidence once.1.10. Documents prepared in a foreign language shall be submitted with a translation into Polish.

Opportunity closing date

27 September 2021

Value of contract

to be confirmed